TABLE 3.
Characteristics of the population in targeted metabolomics analysis groups.
| Characteristics | SP (n = 51) | VP (n = 50) | P |
| Age, y | 57.10 (11.47) | 59.46 (11.65) | 0.446 |
| Male Sex, n (%) | 34 (66.7) | 36 (72) | 0.576 |
| Height, cm | 162.86 (8.11) | 162.60 (7.71) | 0.968 |
| Weight, kg | 67.53 (12.44) | 65.28 (10.36) | 0.582 |
| Smoking, n (%) | 17 (33.3) | 19 (38.0) | 0.867 |
| Drinking, n (%) | 3 (5.9) | 7 (14.0) | 0.394 |
| Hypertension, n (%) | 30 (58.8) | 29 (58.0) | 0.969 |
| Diabetes, n (%) | 12 (23.5) | 15 (30.0) | 0.831 |
| CREA μmol/L | 84.23 (29.22) | 86.71 (30.58) | 0.064 |
| URIC μmol/L | 388.39 (102.33) | 390.32 (125.20) | 0.852 |
| TCHO mmol/L | 4.42 (1.02) | 4.33 (1.16) | 0.773 |
| TG mmol/L | 1.98 (1.94) | 1.74 (1.12) | 0.269 |
| HDLC mmol/L | 1.22 (0.54) | 1.11 (0.26) | 0.366 |
| LDLC mmol/L | 2.94 (1.44) | 3.03 (0.89) | 0.615 |
| EF (%) | 63.10 (7.92) | 65.38 (6.44) | 0.295 |
| Plaque (%) | > 0.001 | ||
| 0 | 51 (100.0) | 0 (0.0) | |
| 1 | 0 (0.0) | 50 (100.0) | |
| NA | 0 (0.0) | 0 (0.0) | |
| Lesion (%) | > 0.001 | ||
| 0 | 3 (5.9) | 8 (16.0) | |
| 1 | 32 (69.7) | 26 (52.0) | |
| 2 | 9 (17.6) | 10 (20.0) | |
| 3 | 7 (13.7) | 6 (12.0) | |
| NA | 0 (0.0) | 0 (0.0) | |
SP, Stable plaque; VP, vulnerable plaque; HC, healthy control; CREA, creatinine; URIC, uric acid; TCHO, total cholesterol; TG, triglyceride; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol; EF, ejection fraction. Continuous variables are presented as mean (SD). Categorical variables are presented as n (%). The bold values of Plaque (%) and lesion (%) mean the plaque and lesion are only two different factors in SP and VP groups.